Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention

Código QR

Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention

Alaa Badawi1, Amira Klip2, Pierre Haddad3, David EC Cole4, Bibiana Garcia Bailo1,5, Ahmed El-Sohemy5, Mohamed Karmali11Office for Biotechnology, Genomics and Population Health, Public Health Agency of Canada, Toronto, ON, Canada; 2Cell Biology Program, The Hospital for Sick Children, Toronto, ON, Ca...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Alaa Badawi, Amira Klip, Pierre Haddad, et al
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2010
Materias:	Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/88cbf4885f79403282a0b01e525c965a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention
por: Badawi A
Publicado: (2010)

The association between obesity, cardiometabolic disease biomarkers, and innate immunity-related inflammation in Canadian adults
por: Da Costa LA, et al.
Publicado: (2012)

Disturbance of inorganic phosphate metabolism in diabetes mellitus: temporary therapeutic intervention trials
por: J&oslash;rn Ditzel, et al.
Publicado: (2009)

Mechanism linking diabetes mellitus and obesity
por: Al-Goblan AS, et al.
Publicado: (2014)

Metabolic syndrome in hemodialysis patients as a risk factor for new-onset diabetes mellitus after renal transplant: a prospective observational study
por: Bonet J, et al.
Publicado: (2013)

Risk factors associated with metabolic syndrome in type 2 diabetes mellitus patients according to World Health Organization, Third Report National Cholesterol Education Program, and International Diabetes Federation definitions
por: Angel Rodr&iacute;guez, et al.
Publicado: (2010)

Minimizing the risk of hypoglycemia in patients with type 2 diabetes mellitus
por: Pamela Kushner
Publicado: (2010)

Management of gestational diabetes mellitus
por: Annunziata Lapolla, et al.
Publicado: (2009)

Achievement of cardiovascular risk factor targets in young adults with diabetes mellitus
por: Peter J Donovan, et al.
Publicado: (2010)

Psychosocial interventions for the diabetic patient
por: Harvey JN
Publicado: (2015)

Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus
por: Lorber D
Publicado: (2014)

Nutritional therapy for the management of diabetic gastroparesis: clinical review
por: Sadiya A
Publicado: (2012)

Effects of Phyllanthus emblica extract on endothelial dysfunction and biomarkers of oxidative stress in patients with type 2 diabetes mellitus: a randomized, double-blind, controlled study
por: Usharani P, et al.
Publicado: (2013)

Plasma Adipsin as a Biomarker and Its Implication in Type 2 Diabetes Mellitus
por: Tafere GG, et al.
Publicado: (2020)

Glucose estimation in the salivary secretion of diabetes mellitus patients
por: Abikshyeet P, et al.
Publicado: (2012)

Evidence-based diabetes nutrition therapy recommendations are effective: the key is individualization
por: Franz MJ, et al.
Publicado: (2014)

Relationship between insulin resistance and plasma vitamin D in adults
por: Badawi A, et al.
Publicado: (2014)

Awareness of diabetic retinopathy among patients with type 2 diabetes mellitus in Jordan
por: Bakkar MM, et al.
Publicado: (2017)

Evaluating the impact of type 2 diabetes mellitus on cardiovascular risk in persons with metabolic syndrome using the UKPDS risk engine
por: Ogedengbe OS, et al.
Publicado: (2015)

Prevalence of diagnosed and undiagnosed diabetes mellitus in adults aged 19 years and older in Basrah, Iraq
por: Mansour AA, et al.
Publicado: (2014)

Sitagliptin as combination therapy in the treatment of type 2 diabetes mellitus
por: Shannon A Miller, et al.
Publicado: (2009)

Sexual dysfunction in diabetic women: prevalence and differences in type 1 and type 2 diabetes mellitus
por: Mazzilli R, et al.
Publicado: (2015)

Obesity and the development of type 2 diabetes: the effects of fatty tissue inflammation
por: Dara P Schuster
Publicado: (2010)

Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus
por: Holl, et al.
Publicado: (2014)

Persistent hypertriglyceridemia in statin-treated patients with type 2 diabetes mellitus
por: Feher M, et al.
Publicado: (2013)

Anti-atherosclerotic effects of sitagliptin in patients with type 2 diabetes mellitus
por: Omoto S, et al.
Publicado: (2015)

Diabetes mellitus and risk factors in human immunodeficiency virus-infected individuals at Jimma University Specialized Hospital, Southwest Ethiopia
por: Mohammed AE, et al.
Publicado: (2015)

Clinical potential of lixisenatide once daily treatment for type 2 diabetes mellitus
por: Petersen AB, et al.
Publicado: (2013)

Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated
por: Irons BK, et al.
Publicado: (2014)

Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies
por: Stanley Schwartz, et al.
Publicado: (2010)

Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated [Corrigendum]
por: Irons BK, et al.
Publicado: (2017)

Critical appraisal of once-weekly formulation of exenatide in the control of type 2 diabetes mellitus
por: Jason Seewoodhary, et al.
Publicado: (2010)

Holistic approach to prevention and management of type 2 diabetes mellitus in a family setting
por: Ofori SN, et al.
Publicado: (2014)

Urinary biomarkers for diagnosing poststroke depression in patients with type 2 diabetes mellitus
por: Liang ZH, et al.
Publicado: (2019)

Disturbance of inorganic phosphate metabolism in diabetes mellitus: clinical manifestations of phosphorus-depletion syndrome during recovery from diabetic ketoacidosis
por: J&oslash;rn Ditzel, et al.
Publicado: (2010)

Optimizing weight control in diabetes: antidiabetic drug selection
por: S Kalra, et al.
Publicado: (2010)

TRC150094 attenuates progression of nontraditional cardiovascular risk factors associated with obesity and type 2 diabetes in obese ZSF1 rats
por: Shitalkumar P Zambad, et al.
Publicado: (2011)

Nutrition therapy for type 2 diabetes: confirmed efficacy on individualized management
por: Wei FX, et al.
Publicado: (2018)

Significance of HbA1c and its measurement in the diagnosis of diabetes mellitus: US experience
por: Juarez DT, et al.
Publicado: (2014)

Type 2 diabetes mellitus development programs in the new regulatory environment with cardiovascular safety requirements
por: Yang F, et al.
Publicado: (2015)